Literature DB >> 6601923

Bronchoalveolar lavage cell--lymphocyte interactions in normal nonsmokers and smokers. Analysis with a novel system.

R D deShazo, D E Banks, J E Diem, J A Nordberg, Y Baser, D Bevier, J E Salvaggio.   

Abstract

We investigated the ability of smoker and nonsmoker pulmonary alveolar macrophages (AM) to facilitate lymphocyte proliferative responses in a novel system allowing separation of lymphocyte and AM effects. Bronchoalveolar lavage cells (BLC) were obtained from 7 nonsmokers and 5 older smokers and cultured with purified peripheral blood lymphocytes (PL) and the mitogen phytohemagglutinin. Increasing amounts of BLC were added such that BLC/PL ratios were 1:100, 1:10, 1:2, 1:1 of either autologous or homologous PL. Lymphocyte proliferation was dose-related, increasing with 1:100 and 1:10 BLC/PL ratios, and decreasing to or below initial responses with 1:2 or 1:1 ratios. Depletion of T-lymphocytes from BLC demonstrated that these effects were mediated by AM. Phytohemagglutinin (PHA) dose-response curves of nonsmokers obtained using autologous or homologous PL were not different. When BLC from smokers were cultured with autologous PL, lymphocyte proliferative responses were less than those of similar cultures from nonsmokers. However, when similar smoker BLC were cultured with homologous PL from nonsmokers, proliferative responses were not different from those of nonsmokers. Peak proliferative responses of peripheral blood mononuclear cells were not different from maximal proliferative responses of PL-BLC cultures at any PHA dose. These data show that human AM provide dose-related help and suppression of mitogen-induced lymphocyte proliferation similar to that reported with peripheral blood macrophages. Smoker AM facilitated mitogen-driven proliferation of homologous PL in a normal fashion, demonstrating the utility of this culture system in distinguishing lymphocyte effects present in autologous cultures.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6601923     DOI: 10.1164/arrd.1983.127.5.545

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  8 in total

1.  Reduction in HLA-DR antigen density on alveolar macrophages of smokers.

Authors:  W Pankow; K Neumann; J Rüschoff; R Schröder; P von Wichert
Journal:  Lung       Date:  1991       Impact factor: 2.584

Review 2.  Down-regulation of immune responses in the lower respiratory tract: the role of alveolar macrophages.

Authors:  P G Holt
Journal:  Clin Exp Immunol       Date:  1986-02       Impact factor: 4.330

Review 3.  Immune and inflammatory function in cigarette smokers.

Authors:  P G Holt
Journal:  Thorax       Date:  1987-04       Impact factor: 9.139

Review 4.  Cigaret smoking and the lung.

Authors:  S Murin; J Hilbert; S J Reilly
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 10.817

5.  Modulation of macrophage suppressive activity and prostaglandin release by lymphokines and interferon: comparison of alveolar, pleural and peritoneal macrophages.

Authors:  P Sestini; A Tagliabue; D Boraschi
Journal:  Clin Exp Immunol       Date:  1984-12       Impact factor: 4.330

6.  Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease.

Authors:  D Valeyre; P Soler; C Clerici; J Pré; J P Battesti; R Georges; A J Hance
Journal:  Thorax       Date:  1988-07       Impact factor: 9.139

7.  Suppressor cell activity of human alveolar macrophages in interstitial lung diseases.

Authors:  E M Fireman; S Ben Efraim; J Greif; S Kivity; M R Topilsky
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

8.  Inhibition of the immunosuppressive activity of resident pulmonary alveolar macrophages by granulocyte/macrophage colony-stimulating factor.

Authors:  N Bilyk; P G Holt
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.